NR2B-NMDA receptor mediated modulation of the tyrosine phosphatase STEP regulates glutamates induced neuronal cell death

Journal of Neurochemistry

Volumn 115, Issue 6, 2010, Pages 1350-1362

  Poddar, Ranjana ^a   Deb, Ishani ^a   Mukherjee, Saibal ^a   Paul, Surojit ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

glutamate; NR2A; NR2B; p38 mitogen activated protein kinase; STEP; tyrosine phosphatase

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROTEIN TYROSINE PHOSPHATASE; STRIATAL ENRICHED TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVATION; EXCITOTOXICITY; FEMALE; GENETIC TRANSCRIPTION; IMMUNOPRECIPITATION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CELLS, CULTURED; FEMALE; GLUTAMIC ACID; HELA CELLS; HUMANS; NEURONS; PREGNANCY; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 78649994240     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07035.x     Document Type: Article

References (60)

1. Arundine M., and, Tymianski M., (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61, 657-668.
2. Barone F. C., Irving E. A., Ray A. M., et al. (2001a) Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med. Res. Rev. 21, 129-145.
3. Barone F. C., Irving E. A., Ray A. M., et al. (2001b) SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J. Pharmacol. Exp. Ther. 296, 312-321.
4. Berridge M. J., Lipp P., and, Bootman M. D., (2000) The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11-21.
5. Bickler P. E., and, Fahlman C. S., (2004) Moderate increases in intracellular calcium activate neuroprotective signals in hippocampal neurons. Neuroscience 127, 673-683.
6. Bolshakov V. Y., Carboni L., Cobb M. H., Siegelbaum S. A., and, Belardetti F., (2000) Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses. Nat. Neurosci. 3, 1107-1112.
7. Boulanger L. M., Lombroso P. J., Raghunathan A., During M. J., Wahle P., and, Naegele J. R., (1995) Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. J. Neurosci. 15, 1532-1544.
8. Braithwaite S. P., Xu J., Leung J., Urfer R., Nikolich K., Oksenberg D., Lombroso P. J., and, Shamloo M., (2008) Expression and function of striatal enriched protein tyrosine phosphatase is profoundly altered in cerebral ischemia. Eur. J. Neurosci. 27, 2444-2452.
9. Bult A., Zhao F., Dirkx Jr. R., Raghunathan A., Solimena M., and, Lombroso P. J., (1997) STEP: a family of brain-enriched PTPs. Alternative splicing produces transmembrane, cytosolic and truncated isoforms. Eur. J. Cell Biol. 72, 337-344.
10. Cao J., Viholainen J. I., Dart C., Warwick H. K., Leyland M. L., and, Courtney M. J., (2005) The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J. Cell Biol. 168, 117-126.
11. Chen Q. X., Perkins K. L., Choi D. W., and, Wong R. K., (1997) Secondary activation of a cation conductance is responsible for NMDA toxicity in acutely isolated hippocampal neurons. J. Neurosci. 17, 4032-4036.
12. Chen W. G., Chang Q., Lin Y., Meissner A., West A. E., Griffith E. C., Jaenisch R., and, Greenberg M. E., (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (New York, NY) 302, 885-889.
13. Cheng A., Wang S., Yang D., Xiao R., and, Mattson M. P., (2003) Calmodulin mediates brain-derived neurotrophic factor cell survival signaling upstream of Akt kinase in embryonic neocortical neurons. J. Biol. Chem. 278, 7591-7599.
14. Choi D. W., and, Rothman S. M., (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171-182.
15. Dirnagl U., Iadecola C., and, Moskowitz M. A., (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
16. Gisabella B., Rowan M. J., and, Anwyl R., (2003) Mechanisms underlying the inhibition of long-term potentiation by preconditioning stimulation in the hippocampus in vitro. Neuroscience 121, 297-305.
17. Grabb M. C., and, Choi D. W., (1999) Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J. Neurosci. 19, 1657-1662.
18. Haelewyn B., Alix P., Maubert E., and, Abraini J. H., (2008) NMDA-induced striatal brain damage and time-dependence reliability of thionin staining in rats. J. Neurosci. Methods 168, 479-482.
19. Horstmann S., Kahle P. J., and, Borasio G. D., (1998) Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro. J. Neurosci. Res. 52, 483-490.
20. Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S., and, Ross M. E., (2001) Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl Acad. Sci. USA 98, 1294-1299.
21. Ingram A. J., James L., Thai K., Ly H., Cai L., and, Scholey J. W., (2000) Nitric oxide modulates mechanical strain-induced activation of p38 MAPK in mesangial cells. Am. J. Physiol. Renal Physiol. 279, F243-F251.
22. Kawasaki H., Morooka T., Shimohama S., Kimura J., Hirano T., Gotoh Y., and, Nishida E., (1997) Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272, 18518-18521.
23. Kim M. J., Dunah A. W., Wang Y. T., and, Sheng M., (2005) Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46, 745-760.
24. Kohr G., (2006) NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res. 326, 439-446.
25. Kumar S., Boehm J., and, Lee J. C., (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2, 717-726.
26. Lipton S. A., and, Rosenberg P. A., (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Eng. J. Med. 330, 613-622.
27. Liu Y., Wong T. P., Aarts M., et al. (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846-2857.
28. Luo J., Wang Y., Yasuda R. P., Dunah A. W., and, Wolfe B. B., (1997) The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol. Pharmacol. 51, 79-86.
29. Moolwaney A. S., and, Igwe O. J., (2005) Regulation of the cyclooxygenase-2 system by interleukin-1beta through mitogen-activated protein kinase signaling pathways: a comparative study of human neuroglioma and neuroblastoma cells. Brain Res. Mol. Brain Res. 137, 202-212.
30. Mottet D., Michel G., Renard P., Ninane N., Raes M., and, Michiels C., (2003) Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J. Cell. Physiol. 194, 30-44.
31. Mukherjee P. K., DeCoster M. A., Campbell F. Z., Davis R. J., and, Bazan N. G., (1999) Glutamate receptor signaling interplay modulates stress-sensitive mitogen-activated protein kinases and neuronal cell death. J. Biol. Chem. 274, 6493-6498.
32. Murray B., Alessandrini A., Cole A. J., Yee A. G., and, Furshpan E. J., (1998) Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc. Natl Acad. Sci. USA 95, 11975-11980.
33. Nguyen T. H., Liu J., and, Lombroso P. J., (2002) Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420. J. Biol. Chem. 277, 24274-24279.
34. Nito C., Kamada H., Endo H., Niizuma K., Myer D. J., and, Chan P. H., (2008) Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J. Cereb. Blood Flow Metab. 28, 1686-1696.
35. Park J. G., Yuk Y., Rhim H., Yi S. Y., and, Yoo Y. S., (2002) Role of p38 MAPK in the regulation of apoptosis signaling induced by TNF-alpha in differentiated PC12 cells. J. Biochem. Mol. Biol. 35, 267-272.
36. Paul S., and, Connor J,. (2010) NR2B-NMDA receptor mediated increases in intracellular Ca2+ concentration regulate the tyrosine phosphatase, STEP, and ERK MAP kinase signaling. J. Neurochem. 114, 1107-1118.
37. Paul S., Snyder G. L., Yokakura H., Picciotto M. R., Nairn A. C., and, Lombroso P. J., (2000) The Dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway. J. Neurosci. 20, 5630-5638.
38. Paul S., Nairn A. C., Wang P., and, Lombroso P. J., (2003) NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat. Neurosci. 6, 34-42.
39. Paul S., Olausson P., Venkitaramani D. V., et al. (2007) The striatal enriched protein tyrosine phosphatase gates long-term potentiation and fear memory in the lateral amygdala. Biol. Psychiatry 61, 1049-1061.
40. Paxinos G., and, Watson C., (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
41. Poddar R., and, Paul S., (2009) Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J. Neurochem. 110, 1095-1106.
42. Pulido R., Zuniga A., and, Ullrich A., (1998) PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J. 17, 7337-7350.
43. Raval A. P., Dave K. R., Mochly-Rosen D., Sick T. J., and, Perez-Pinzon M. A., (2003) Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J. Neurosci. 23, 384-391.
44. Rockwell P., Martinez J., Papa L., and, Gomes E., (2004) Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell. Signal. 16, 343-353.
45. Rodrigues S. M., Schafe G. E., and, LeDoux J. E., (2001) Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning. J. Neurosci. 21, 6889-6896.
46. Runden E., Seglen P. O., Haug F. M., Ottersen O. P., Wieloch T., Shamloo M., and, Laake J. H., (1998) Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J. Neurosci. 18, 7296-7305.
47. Semenov D. G., Samoilov M. O., and, Lazarewicz J. W., (2002) Calcium transients in the model of rapidly induced anoxic tolerance in rat cortical slices: involvement of NMDA receptors. Neuro-Signals 11, 329-335.
48. Snyder E. M., Nong Y., Almeida C. G., et al. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 1051-1058.
49. Stanciu M., and, DeFranco D. B., (2002) Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J. Biol. Chem. 277, 4010-4017.
50. Tauskela J. S., and, Morley P., (2004) On the role of Ca2+ in cerebral ischemic preconditioning. Cell Calcium 36, 313-322.
51. Thomas G. M., and, Huganir R. L., (2004) MAPK cascade signalling and synaptic plasticity. Nat. Rev. Neurosci. 5, 173-183.
52. Thompson R. J., Jackson M. F., Olah M. E., Rungta R. L., Hines D. J., Beazely M. A., MacDonald J. F., and, MacVicar B. A., (2008) Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus. Science (New York, NY) 322, 1555-1559.
53. Tovar K. R., and, Westbrook G. L., (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 19, 4180-4188.
54. Tu W., Xu X., Peng L., et al. (2010) DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140, 222-234.
55. Walker D. L., and, Davis M., (2008) Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test. Learn. Mem. (Cold Spring Harbor, NY) 15, 67-74.
56. Wang Q., Walsh D. M., Rowan M. J., Selkoe D. J., and, Anwyl R., (2004) Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 24, 3370-3378.
57. Waxman E. A., and, Lynch D. R., (2005) N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase. J. Biol. Chem. 280, 29322-29333.
58. Xu J., Kurup P., Zhang Y., Goebel-Goody S. M., Wu P. H., Hawasli A. H., Baum M. L., Bibb J. A., and, Lombroso P. J., (2009) Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J. Neurosci. 29, 9330-9343.
59. Zhao M. G., Toyoda H., Lee Y. S., et al. (2005) Roles of NMDA NR2B subtype receptor in pre long-term potentiation and contextual fear memory. Neuron 47, 859-872.
60. Zhu J. J., Qin Y., Zhao M., Van Aelst L., and, Malinow R., (2002) Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell 110, 443-455.